Andreas Stolle News Today : Breaking News, Live Updates & Top Stories | Vimarsana

04.29.21 -- COVID-19's Impact On Outsourced Small Molecule Manufacturing     Catching up to the paradigm shift in optimizing, scaling up, and manufacturing plasmids is crucial for clinical to commercial program success for gene therapies and vaccines. With an increased demand for plasmids for targeted gene therapeutic delivery, partnering with a CDMO equipped with the capacity, expertise, and equipment for plasmid DNA production is critical to ensuring a stable therapeutic supply. Join Aji Bio-Pharma to learn about methodologies to ensure effective producti...

01.28.21 -- When Pharmaceutical Automation Projects Fail: Averting Disaster Through Risk Assessment     With the spread of SARS-CoV-2 (COVID-19) intensifying, scientists, together with pharmaceutical companies, are reinventing the approach of how to bring life-saving drugs to market. Attend this webinar to learn more about bringing life-saving drugs to market faster without impacting product quality, safety, or efficacy and the impacts and comparisons of classic platforms vs. new-generation platforms. And more!   By Tim Sandle, Ph.D., Bio Products Laborato...

12.17.20 -- FDA FY2020 Drug Inspection Observations And Trends   ISR’s Health Panel includes managers, directors, executives, and subject matter experts in clinical development and drug manufacturing who work at pharma companies, service provider companies, and research sites. Members are paid for their time (a 15-minute survey may pay $40, whereas a 45-minute phone interview may pay $150) and they get to choose which research opportunities to participate in. Apply here. Featured Editorial   This article presents the FDA's most recent publication of GMP ...

12.10.20 -- Bioprocessing Year In Review: 11 Key Trends Accelerated By COVID-19     Nanoform Finland Plc (Nanoform), an innovative nanoparticle medicine enabling company, will be featured in an upcoming Advancements episode broadcasting via CNBC on Saturday, December 12, at 2:30 p.m. (ET). Viewers will learn how Nanoform’s award-winning CESS® nanoparticle engineering technology can potentially double the number of drug candidates progressing into clinic. Featured Editorial By Ronald A. Rader and Eric S. Langer, BioPlan Associates, Inc. Despite the morbid...